Spravato Prior Authorization delays are still one of the biggest reasons clinics lose revenue, postpone treatment, and struggle with patient retention in 2026.
Most providers assume the challenge starts after the claim is submitted. In reality, the process usually breaks much earlier. Missing eligibility details, incomplete clinical documentation, incorrect diagnosis pairing, and payer-specific rule changes often create avoidable delays before treatment even begins.
For psychiatric practices offering Spravato, Prior Authorization is no longer an administrative task. It is one of the most important revenue cycle events in the entire treatment workflow.
At Finnastra, we see this every day. Clinics with strong clinical outcomes still face approval delays because their authorization workflows are inconsistent or outdated.
That is why our Spravato Billing Services are designed to simplify eligibility verification, authorization submission, payer communication, coding alignment, and reimbursement tracking from start to finish.
Many clinics are surprised when a medically appropriate patient still receives a denial or pending status.
The issue usually comes from workflow gaps, not medical necessity.
Common causes of delayed Spravato Prior Authorization include:
According to industry RCM benchmarks, nearly 20% to 30% of healthcare claim denials originate from authorization-related issues. Behavioral health practices dealing with specialty medications often experience even higher rates due to payer scrutiny and changing policies.
For Spravato providers, one delayed authorization can affect scheduling, staffing, medication purchasing, and patient adherence at the same time.
A delayed authorization does not only affect patient access.
It affects cash flow.
Clinics operating under Buy and Bill models often purchase medication before final payer confirmation. If the authorization process fails, practices risk delayed reimbursement, underpayment, or complete denial.
This becomes more serious for high-volume clinics.
A practice treating 40 to 50 Spravato patients per month can lose substantial monthly revenue from unresolved authorizations, expired approvals, or eligibility errors.
As a leading Spravato Billing Services Company, Finnastra ensures clinics avoid these gaps by building workflows that connect Prior Authorization, eligibility verification, coding, and claims management together.
Successful Spravato programs rarely rely on manual follow-up or disconnected systems.
They build authorization workflows around speed, documentation quality, and payer behavior tracking.
At Finnastra, we help clinics:
We confirm:
This prevents last-minute surprises that delay treatment or create unpaid balances.
Many payers now expect detailed clinical support before approving Spravato treatment.
We help clinics organize:
When documentation matches payer expectations from the beginning, approval timelines improve significantly.
Not every payer reviews Spravato requests the same way.
Some require step therapy documentation. Others focus heavily on treatment-resistant depression criteria or frequency restrictions.
When you work with a dedicated Spravato Billing Company like Finnastra, your team no longer needs to guess what each payer expects.
We support Spravato Prior Authorization with payer-specific workflows designed to reduce repeated submissions and unnecessary delays.
One issue clinics rarely discuss openly is patient drop-off during authorization delays.
Long waiting periods create frustration for patients already struggling with severe depression symptoms. Delays between evaluation and treatment often reduce adherence before therapy even begins.
Clinics with faster authorization turnaround times usually experience:
This is especially important in competitive behavioral health markets where patient experience directly impacts referrals and program growth.
Our team handles the front-end revenue cycle processes that directly impact approval speed and reimbursement accuracy.
We help clinics:
As a Top Spravato Billing Company in U.S, Finnastra supports clinics with operational workflows built specifically for Spravato, Ketamine, TMS, and behavioral health reimbursement.
Spravato reimbursement success starts long before claim submission.
Eligibility verification and Prior Authorization determine whether clinics get paid correctly, how quickly treatment begins, and whether patients stay engaged in care.
Practices that improve these two areas usually see better revenue stability, fewer denials, stronger retention, and smoother operational growth.
Our Spravato Billing Services are designed to simplify complex authorization workflows while helping clinics reduce delays and improve reimbursement performance.
If your clinic is struggling with Spravato Prior Authorization delays, inconsistent approvals, Buy and Bill confusion, or eligibility issues, Finnastra can help you build a faster and more reliable process.
